InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Greene Rick S., 董事. Director active across 1 company, notably HCW Biologics Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €44k. History available since 25 August 2021. The latest transaction was filed on 8 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Greene Rick S. is a Board Member at HCW Biologics Inc. He plays a key role in the governance of the company, contributing to strategy and oversight of operations. His experience in the biopharmaceutical sector is an asset for HCW Biologics.